amoxicillin heumann 1000 mg tabletten
amoxicillin heumann 500 mg tabletten
cefuroxim-ct 250mg filmtabletten
cefuroxim-ct 500mg filmtabletten
respreeza
csl behring gmbh - alpha1-proteinase inhibitor (human) - genetic diseases, inborn, lung diseases - antihemorrhagics, - respreeza is indicated for maintenance treatment, to slow the progression of emphysema in adults with documented severe alpha1-proteinase inhibitor deficiency (e.g. genotypes pizz, piz(null), pi(null,null), pisz). patients are to be under optimal pharmacologic and non-pharmacologic treatment and show evidence of progressive lung disease (e.g. lower forced expiratory volume per second (fev1) predicted, impaired walking capacity or increased number of exacerbations) as evaluated by a healthcare professional experienced in the treatment of alpha1-proteinase inhibitor deficiency.,
sinestic turbuhaler 160 mikrogram/4,5 mikrogram/inhalation inhalationspulver
symbicort turbuhaler 160 mikrogram/4,5 mikrogram/inhalation inhalationspulver
symbicort turbuhaler 160 mikrogram/4,5 mikrogram/inhalation inhalationspulver
symbicort turbuhaler 160 mikrogram/4,5 mikrogram/inhalation inhalationspulver
symbicort turbuhaler 160 mikrogram/4,5 mikrogram/inhalation inhalationspulver